In KRAS MT/p53 WT NSCLC cells, Rac1 and phalloidin aggregated outside the membrane, forming protrusions and ruffling with upregulated Rac1 expression after nutlin-3a treatment (Fig. 3G, H). Here, KRAS is linked to non-small cell lung carcinoma.